We are live on
!
Find out more
RVNC
Revance Therapeutics, Inc.
RVNC
RVNC
Delisted
RVNC was delisted on the 5th of February, 2025.
110 hedge funds and large institutions have $957M invested in Revance Therapeutics, Inc. in 2018 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 47 increasing their positions, 28 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
68% more repeat investments, than reductions
Existing positions increased: 47 | Existing positions reduced: 28
34% more call options, than puts
Call options by funds: $2.94M | Put options by funds: $2.19M
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
8% less funds holding
Funds holding: 120 → 110 (-10)
9% less capital invested
Capital invested by funds: $1.05B → $957M (-$96.8M)
38% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 24
Holders
110
Holders Change
-10
Holders Change %
-8.33%
% of All Funds
2.52%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
15
Increased
47
Reduced
28
Closed
24
Calls
$2.94M
Puts
$2.19M
Net Calls
+$746K
Net Calls Change
-$1.04M
Top Buyers
| 1 |
Capital World Investors
Los Angeles,
California
|
+$43.1M |
| 2 |
BlackRock
New York
|
+$15.7M |
| 3 |
JP Morgan Chase
New York
|
+$6.85M |
| 4 |
AllianceBernstein
Nashville,
Tennessee
|
+$5.14M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$4.68M |
Top Sellers
| 1 |
PA
Perceptive Advisors
New York
|
-$19.1M |
| 2 |
Franklin Resources
San Mateo,
California
|
-$15.6M |
| 3 |
EWM
Essex Woodlands Management
The Woodlands,
Texas
|
-$15M |
| 4 |
Millennium Management
New York
|
-$12.3M |
| 5 |
Jennison Associates
New York
|
-$10.6M |
